Note: This document contains side effect information about ropivacaine. Some dosage forms listed on this page may not apply to the brand name Naropin.
Summary
Common side effects of Naropin include: hypotension and nausea. Other side effects include: bradycardia and vomiting. Continue reading for a comprehensive list of adverse effects.
Applies to ropivacaine: injection solution.
Serious side effects of Naropin
Along with its needed effects, ropivacaine (the active ingredient contained in Naropin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking ropivacaine:
More common
- Blurred vision
- chest pain or discomfort
- confusion
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- lightheadedness, dizziness, or fainting
- slow or irregular heartbeat
- sweating
- unusual tiredness or weakness
Less common
- Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- chills
- decrease in frequency or amount of urine
- difficulty in passing urine (dribbling)
- fever
- painful urination
Rare
- Absence of or decrease in body movement
- agitation
- anxiety
- bluish color of the skin or changes in skin color
- changes in vision
- clumsiness
- continuing ringing or buzzing or other unexplained noise in the ears
- cough
- decreased awareness or responsiveness
- difficulty breathing
- drooping upper eyelids
- drowsiness
- fast or irregular heartbeat
- general feeling of discomfort or illness
- hearing loss
- loss of appetite
- loss of consciousness
- low body temperature
- mood or mental changes
- muscle aches
- muscle spasms (tetany) or twitching seizures
- muscle weakness
- nausea
- nervousness
- noisy breathing
- pain or discomfort in the arms, jaw, back, or neck
- pain, redness, or swelling in the arm or leg
- problems with memory
- seeing or hearing things that are not there
- seizures
- severe sleepiness
- severe, unusual tiredness or weakness
- shivering
- slow heartbeat
- swelling of the foot or leg tenderness
- tightness in the chest
- trembling
- trouble sleeping
- vomiting
- weak or feeble pulse
- weight gain
- yellow skin or eyes
Incidence not known
- Anxiety
- depression
- difficulty swallowing
- excitation
- fast, irregular, pounding, or racing heartbeat or pulse
- hives, itching, skin rash
- inability to breathe without assistance
- paralysis of the arms
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- restlessness
- slow heartbeat
- tremors
Other side effects of Naropin
Some side effects of ropivacaine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Headache
Less common
- Anxiety
- runny or stuffy nose
- sneezing
Rare
- Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
- difficulty in moving
- frequent urge to defecate
- joint pain or swelling
- lack or loss of strength
- loss of bowel control
- muscle pain, cramps, or stiffness
- straining while passing stool
For Healthcare Professionals
Applies to ropivacaine: injectable solution.
General
Reactions to this drug are characteristic of those associated with other amide-type local anesthetics. A major cause of side effects can me associated with excessive plasma levels which may be due to overdose, unintentional intravascular injection, or slow metabolic degradation.[Ref]
Cardiovascular
Very common (10% or more): Hypotension (up to 54.6%), bradycardia (up to 19.5%), fetal bradycardia (12.1%)
Common (1% to 10%): Hypertension, tachycardia, chest pain, fetal tachycardia, fetal distress
Uncommon (0.1% to 1%): Syncope, severe hypotension
Rare (less than 0.1%): Cardiac arrest, cardiac arrhythmia
Frequency not reported: Vasovagal reaction, postural hypotension, non-specific ECG abnormalities, extrasystole, nonspecific arrhythmia, atrial fibrillation, ST segment changes, myocardial infarction, deep vein thrombosis, phlebitis, pulmonary embolism[Ref]
Nervous system
Common (1% to 10%): Paresthesia, headache, dizziness, hypoesthesia
Uncommon (0.1% to 1%): CNS toxicity, convulsion, grand mal convulsions, seizure, lightheadedness, circumoral paresthesia, numbness of the tongue, hyperacusis, dysarthria, tremor
Frequency not reported: Horner's syndrome, paresis, dyskinesia, neuropathy, coma, convulsion, hypokinesia, hypotonia, ptosis, stupor, spinal cord dysfunction, anterior spinal artery syndrome, arachnoiditis, cauda equine, total spinal block, persistent anesthesia, weakness, paralysis of lower extremities, loss of sphincter control, septic meningitis[Ref]
Local
Frequency not reported: Injection site pain[Ref]
Gastrointestinal
Very common (10% or more): Nausea (up to 29.4%), vomiting (up to 14.6%)
Common (1% to 10%): Neonatal vomiting
Frequency not reported: Fecal incontinence, tenesmus[Ref]
Other
Common (1% to 10%): Fever, pain, postoperative complication, rigors, neonatal complication, Apgar score low, neonatal fever, neonatal infection, temperature elevation, chills
Uncommon (0.1% to 1%): Tinnitus, hypothermia, neonatal sepsis
Frequency not reported: Malaise, asthenia, accident/injury, hearing abnormal, vertigo[Ref]
Genitourinary
Common (1% to 10%): Urinary retention, oliguria, urinary tract infection, progression of labor poor/failed
Frequency not reported: Uterine atony, urinary incontinence, micturition disorder[Ref]
Dermatologic
Common (1% to 10%): Pruritus
Rare (less than 0.1%): Angioedema, urticaria
Frequency not reported: Rash[Ref]
Hematologic
Common (1% to 10%): Anemia[Ref]
Hepatic
Common (1% to 10%): Neonatal jaundice
Frequency not reported: Jaundice[Ref]
Metabolic
Common (1% to 10%): Hypokalemia, neonatal hypoglycemia
Uncommon (0.1% to 1%): Fetal acidosis
Frequency not reported: Hypomagnesemia[Ref]
Musculoskeletal
Very common (10% or more): Back pain (up to 16.4%)
Common (1% to 10%): Cramps
Uncommon (0.1% to 1%): Muscular twitch, muscular rigidity, hypotonia
Frequency not reported: Myalgia[Ref]
Ocular
Frequency not reported: Vision abnormal, vision blurred, pupil constriction[Ref]
Psychiatric
Common (1% to 10%): Anxiety, insomnia
Frequency not reported: Agitation, confusion, somnolence, nervousness, amnesia, hallucination, emotional lability, nightmares, restlessness, drowsiness, unconsciousness[Ref]
Respiratory
Common (1% to 10%): Dyspnea, rhinitis, neonatal respiratory disorder, neonatal tachypnea, hypoxia, hypercapnia, apnea
Frequency not reported: Bronchospasm, coughing, underventilation, apnea, respiratory paralysis[Ref]
Endocrine
Common (1% to 10%): Breast disorder/breastfeeding disorder[Ref]
Immunologic
Rare (less than 0.1%): Allergic reaction, anaphylactic reaction[Ref]